IRADIMED CORP - Common (IRMD)

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / Common
Shares outstanding
12,602,265
Total 13F shares
6,716,470
Share change
+349,365
Total reported value
$295,435,220
Put/Call ratio
26%
Price per share
$43.99
Number of holders
125
Value change
+$14,779,015
Number of buys
77
Number of sells
50

Institutional Holders of IRADIMED CORP - Common (IRMD) as of Q1 2024

As of 31 Mar 2024, IRADIMED CORP - Common (IRMD) was held by 125 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,716,470 shares. The largest 10 holders included Nine Ten Capital Management LLC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, Copeland Capital Management, LLC, Soleus Capital Management, L.P., RK Capital Management, LLC, Bares Capital Management, Inc., Ranger Investment Management, L.P., and DIMENSIONAL FUND ADVISORS LP. This page lists 125 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.